Menu
Back to Journals » Cancer Management and Research » Volume 11
Review
Nivolumab plus ipilimumab combination therapy for the first-line treatment NSCLC: evidence to date
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,621 | Dovepress* | 6,654+ | 1,399 | 8,053 | |
| PubMed Central* | 3,967 | 808 | 4,775 | ||
| Totals | 10,621 | 2,207 | 12,828 | ||
| *Since 29 May 2019 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 1 | 1 | 3 |
View citations on PubMed Central and Google Scholar